Vitruvias Therapeutics, Inc Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency
- Date
- Aug 21, 2026
- Company
- Vitruvias Therapeutics, Inc
- Brand
- Vitruvias Therapeutics
- Product
- Thyroid Tablets, USP 30 mg
- Reason
- Potential for the Product to be Superpotent
- Hazard
- Other
- Source
- FDA
How to identify the product
- (August 21, 2026) – Vitruvias Therapeutics Inc. is voluntarily recalling one lot (Lot.
- To best identify the product, the NDC, Product Description, Lot Number, and Expiration Date are listed below.
- Lot 504950 was distributed nationwide in the USA to Vitruvias Therapeutics' direct accounts from Jan. 31, 2025 to Sept. 30, 2025.
- Patients who are currently taking Thyroid, USP from Lot 504950, which is being recalled, should not discontinue use without contacting their healthcare provider for further guidance and/or a replacement prescription.
Product photos are on the official FDA page.
Facts are taken from the official notice. If anything here differs from it, the official notice is correct.